Yuzo Kikuchi
Kanazawa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuzo Kikuchi.
International Journal of Molecular Sciences | 2014
Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koichi Wakamatsu; Yuzo Kikuchi
This study investigated the clinical outcomes of a 4-fraction stereotactic radiotherapy (SRT) study using helical tomotherapy for brain metastases. Between August 2009 and June 2013, 54 patients with a total of 128 brain metastases underwent SRT using tomotherapy. A total dose of 28 or 28.8 Gy at 80% isodose was administered in 4 fractions for all tumors. The mean gross tumor volume (GTV) was 1.9 cc. Local control (LC) rates at 6, 12, and 18 months were 96%, 91%, and 88%, respectively. The 12-month LC rates for tumors with GTV ≤0.25, >0.25 and ≤1, and >1 cc were 98%, 82%, and 93%, respectively; the rates were 92% for tumors >3 cc and 100% for >10 cc. The 6-month rates for freedom from distant brain failure were 57%, 71%, and 55% for patients with 1, 2, and ≥3 brain metastases, respectively. No differences were significant. No major complications were observed. The 4-fraction SRT protocol provided excellent tumor control with minimal toxicity. Distant brain failure was not so frequent, even in patients with multiple tumors. The results of the current study warrant a prospective randomized study comparing single-fraction stereotactic radiosurgery (SRS) with SRT in this patient population.
BioMed Research International | 2014
Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koji Inoda; Yuzo Kikuchi
Stereotactic body radiotherapy (SBRT) proved to be an effective treatment with acceptable toxicity for lung tumors. However, the use of helical intensity-modulated (IM) SBRT is controversial. We investigated the outcome of lung tumor patients treated by IMSBRT using helical tomotherapy with a Japanese standard fractionation schedule of 48 Gy in 4 fractions (n = 37) or modified protocols of 50–60 Gy in 5–8 fractions (n = 35). Median patients age was 76 years and median follow-up period for living patients was 20 months (range, 6–46). The median PTV was 6.9 cc in the 4-fraction group and 14 cc in the 5- to 8-fraction group (P = 0.001). Grade 2 radiation pneumonitis was seen in 2 of 37 patients in the 4-fraction group and in 2 of 35 patients in the 5- to 8-fraction group (log-rank P = 0.92). Other major complications were not observed. The LC rates at 2 years were 87% in the 4-fraction group and 83% in the 5- to 8-fraction group. Helical IMSBRT for lung tumors is safe and effective. Patients with a high risk of developing severe complications may also be safely treated using 5–8 fractions. The results of the current study warrant further studies of helical IMSBRT.
Journal of Medical Imaging and Radiation Oncology | 2011
Shiro Miyayama; Masashi Yamashiro; Yuki Hattori; Nobuaki Orito; Ken Matsui; Kazunobu Tsuji; Miki Yoshida; Masanori Yoshida; Yuzo Kikuchi; Taeko Tanaka; Gota Tsuda; Osamu Matsui
Purpose of the study: To evaluate the usefulness of C‐arm computed tomography (CT) during superselective intra‐arterial infusion chemotherapy for advanced head and neck carcinoma.
Journal of Radiation Research | 2017
Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koji Inoda; Yuzo Kikuchi
Abstract This study investigated the differences in dose–volume parameters for the breast and normal tissues during TomoDirectTM (TD) intensity-modulated radiation therapy (IMRT), TD-3D conformal radiotherapy (3DCRT) and 3DCRT plans, all using two beams, and analyzed treatment outcomes of two-beam TD-IMRT for breast cancer after breast-conserving surgery. Between August 2011 and January 2015, 152 patients were treated using two-beam TD-IMRT with 50 Gy/25 fractions. Among them, 20 patients with left-sided breast cancer were randomly chosen, and two-beam TD-IMRT, TD-3DCRT and 3DCRT plans were created for each patient. The homogeneity and conformity indices and various dose–volume parameters for the planning target volume and OARs were evaluated. Clinical outcomes were evaluated at 3 years. Toxicities were evaluated using the Common Terminology Criteria for Adverse Events version 4.0. TD-IMRT and TD-3DCRT showed better whole-breast coverage than 3DCRT (P < 0.001). Most of the mean values of dosimetric endpoints for OARs were better in TD-IMRT than in TD-3DCRT and 3DCRT. Overall survival rates were 97.7% and local control rates were 99.1% at 3 years. Regional control and distant metastasis control rates at 3 years were 98.6% and 96.8%, respectively. Twenty-four of the 152 patients had Grade 2 or higher acute radiation dermatitis. Four patients (4/146 = 2.7%) had Grade 2 radiation pneumonitis. There were no late adverse events of Grade 2 or higher. Two-beam TD-IMRT appeared to yield better dose distribution for whole-breast external-beam radiation therapy than TD-3DCRT and two-beam 3DCRT. The treatment appeared to provide low skin toxicity and acceptable tumor control.
Medical Imaging 2007: Physics of Medical Imaging | 2007
Tatsuhiko Matsushita; Toshiaki Miyati; Kazuya Nakayama; Takashi Hamaguti; Yoshihiko Hayakawa; Allan G. Farman; Yuzo Kikuchi
We developed a novel system for imaging and qualitative analysis of surface vessels using near infrared (NIR) radiation with tuned aperture computed tomography (TACT®), even if the NIR cannot transmit through thick regions. NIR-sensitive CCD camera was surrounded by sixty light emitting diodes (alternating wavelengths of 700 nm and 810 nm), and could only detect the NIR from the subcutaneous tissue. We obtained multiple near infrared projections of surface vessels at each wavelength in accordance with the optical aperture theory within one second. Then, we created tomograms using the TACT program, and determined the venous oxygenation index (VOI), which reflected the oxygen saturation level, calculated from the image signals at each wavelength. This system produced thinner NIR tomograms under 0.5 mm. The change in VOI after load test calculated from NIR tomograms was more sensitive than that from NIR images without tomography. Our novel system makes it possible to non-invasively obtain NIR tomograms and accurately analyze changes in oxygen saturation.
Medical Imaging 2005: Visualization, Image-Guided Procedures, and Display | 2005
Rie Tanaka; Shigeru Sanada; Takeshi Kobayashi; Masayuki Suzuki; Yuzo Kikuchi; Takeshi Matsui; Osamu Matsui
External beam radiation therapy is becoming more common due to the increase in cancer rate because of the aging of society and respect for quality of life. Accurate radiation therapy planning is crucial to prevent cancer recurrence and damage to normal tissues. However, the margin for respiratory movement is commonly set based on the operators’ experience, and sometimes lacks reproducibility and is not quantitative. The present study was performed to develop a computer-assisted system for setting appropriate margins of organs with respiratory movement in radiation therapy planning. Frontal and lateral chest fluoroscopic images (43×43cm) were obtained during respiration using a dynamic flat-panel detector system. Computer tomography (CT) images were obtained for radiation therapy planning, and digital reconstructed radiographs (DRRs) were created. The respiratory level of CT images was determined by measuring the distance from the lung apex to the diaphragm in DRR, and then one of the fluoroscopic images in the same respiratory level was determined. The thoracic vertebrae were automatically determined as landmarks, and then image registration between DRRs and fluoroscopic images was performed by template-matching. The range of respiratory movement of the target area in the lung was then measured in fluoroscopic images. The quantified range of respiratory movement was then correlated to CT data, and the appropriate margin for respiratory movement was displayed as 3D volume data in the lung. Our system could provide accurate margins for respiratory movement based on the quantified range of movement of the target in the lung during respiration.
Gynecologic Oncology | 2006
Kiichiro Noda; Yasuo Ohashi; Hajime Sugimori; Masami Ozaki; Hideo Niibe; Sachio Ogita; Ichiro Kohno; Kazuo Hasegawa; Yuzo Kikuchi; Yoshihiro Takegawa; Shingo Fujii; Kenichi Tanaka; Kazunori Ochiai; Midori Kita; Keiichi Fujiwara
Japanese Journal of Clinical Oncology | 2006
Kiichiro Noda; Yasuo Ohashi; Hiroji Okada; Sachio Ogita; Masami Ozaki; Yuzo Kikuchi; Yoshihiro Takegawa; Hideo Niibe; Shingo Fujii; Junichi Horiuchi; Kozo Morita; Shozo Hashimoto; Keiichi Fujiwara
Nihon Hōshasen Gijutsu Gakkai zasshi | 2005
Rie Tanaka; Masanori Matsushima; Yuzo Kikuchi; Shigeru Sanada
J Jpn Soc Ther Radiol Oncol | 1997
Nobukazu Fuwa; Yoshiyuki Ito; Eriko Kato; Minoru Kamata; Yuzo Kikuchi; Kozo Morita